Alpha-l-fucosidase as a tumour marker of hepatocellular carcinoma

Arab Journal of Gastroenterology

Volumn 13, Issue 1, 2012, Pages 9-13

  Fawzy Montaser, Mohamed ^a   Amin Sakr, Mohamed ^a   Omar Khalifa, Mohamed ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Alpha l fucosidase; HCC; Tumour marker

Indexed keywords

ALPHA LEVO FUCOSIDASE;

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; CANCER PROGNOSIS; CASE CONTROL STUDY; CHEMOLUMINESCENCE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

ADULT; ALPHA-L-FUCOSIDASE; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84860446932     PISSN: 16871979     EISSN: 20902387     Source Type: Journal    
DOI: 10.1016/j.ajg.2012.03.006     Document Type: Article

References (22)

1. Llovet J.M., Burroughs A., Bruix J. Hepatocellular carcinoma. Lancet 2003, 362(9399):1907-1917.
2. Shi M., Zhang C.Q., Zhang Y.Q., et al. Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin. World J Surg 2004, 28(4):376-381.
3. Yao D.F., Dong Z.Z., Yao M. Specific molecular markers in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2007, 6(3):241-247.
4. Elshemey W.M., Desouky O.S., Mohammed M.S., et al. Carcinoma using low-angel x-ray scattering signatures of serum. Phys Med Biol 2003, 48(17):N239-N246.
5. Nakatsura T., Yoshitake Y., Senju S., et al. Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochem Biophys Res Commun 2003, 306(1):16-25.
6. Giardina M.G., Matarazzo M., Morante R., et al. Serum α-l-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis. Cancer 1998, 83(12):2468-2474.
7. Tangkijvanich P., Tosukhowong P., Bunyongyod P., et al. Alpha-l-fucosidase as a serum marker of hepatocellular carcinoma in Thailand. Southeast Asian J Trop Med Public Health 1999, 30(1):110-114.
8. Giardina M.G., Matarazzo M., Varriale A., et al. Serum alpha-l-fucosidase: a useful marker in the diagnosis of hepatocellular carcinoma. Cancer 1992, 70(5):1044-1048.
9. Ma J., Gong Q., Lin M., et al. Combined five tumor markers in detecting primary hepatic carcinoma. Zhonghua Wai Ke Za Zhi 2000, 38(1):14-16.
10. Li C., Qian J., Lin J.S. Purification and characterization of α-l-fucosidase from human primary hepatocarcinoma tissue. World J Gastroenterol 2006, 12(23):3770-3775.
11. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42(5):1208-1236.
12. Christensen E., Schlichting P., Fauerholdt L. Prognostic value of child-turcotte criteria in medically treated cirrhosis. Hepatology 1984, 4(3):430-435.
13. Zielke K., Okada S., O'Brien J.S. Fucosidosis: diagnosis by serum assay of α-l-fucosidase. J Lab Clin Med 1972, 79(1):164-169.
14. El Zayadi A.R., Badran H.M., Barakat E.M.F., et al. Hepatocellular carcinoma in Egypt: a single center study over a decade. World J Gastroenterol 2005, 11(3):5193-5198.
15. Abdel Wahab M., El Ghawalby N., Mostafa M., et al. Epidemiology of hepatocellular carcinoma in Lower Egypt, Mansoura Gastroenterology Center. Hepato-Gastroenterol 2007, 54(73):157-162.
16. Moriya K., Fujie H., Shintani Y., et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998, 4(9):1065-1067.
17. Sakamuro D., Furukawa T., Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 1995, 69(6):3893-3896.
18. Nair S., Shivakumar K.S., Thuluvath P.J. Mortality from hepatocellular and biliary cancers: changing epidemiological trends. Am J Gastroenterol 2002, 97(1):167-171.
19. Esmat G., Zakaria S., Khatab H., et al. Impact of Hepatitis C Virus (HCV) genotype and viral load on the biochemical and histopathological liver profiles in Egyptian patients infected with HCV. Hepatology 2002, 36(4):535A.
20. El Houseini M.E., Sherbiny M.E., Awad M.E., et al. Serum alpha-l-fucosidase enzyme activity as a marker for hepatocellular carcinoma: comparison with AFP using ROC analysis. J Egypt Natl Cancer Inst 2001, 13(4):277-283.
21. Bukofzer S., Stass P.M., Kew M.C., et al. Alpha-l-fucosidase as a serum marker of hepatocellular carcinoma in Southern African blacks. Br J Cancer 1989, 59(3):417-420.
22. Wang J.J., Cao E.H. Rapid kinetic rate assay of the serum α-l-fucosidase in patients with hepatocellular carcinoma by using a novel substrate. Clin Chim Acta 2004, 347(1-2):103-109.